Innovative medicines are an essential resource in improving the quality of health care while holding down costs. Biopharmaceutical research and development is also a key driver of economic growth and employment in Indiana. As our nation embarks on health care reform, a critical measure of any proposal is whether it promotes or limits the ability to develop new therapies and bring them to patients.  Lilly has staked its future on a strategy of innovation. We are transforming our company to speed new medicines to patients, and we are actively involved in the health care reform debate to help ensure that patients continue to benefit from medical innovation.